首页>
外国专利>
GENE SIGNATURE OF RESIDUAL RISK FOLLOWING ENDOCRINE TREATMENT IN EARLY BREAST CANCER
GENE SIGNATURE OF RESIDUAL RISK FOLLOWING ENDOCRINE TREATMENT IN EARLY BREAST CANCER
展开▼
机译:早期乳腺癌后内分泌治疗后残留风险的基因特征
展开▼
页面导航
摘要
著录项
相似文献
摘要
There is described herein a method of prognosing endocrine-only treatment in a subject with breast cancer, the method comprising: a) providing a tumor sample of the breast cancer; b) determining the expression level of at least 40 of the genes listed in Table 4 in the tumor sample; c) comparing said expression levels to a reference expression level of the group of genes from control samples from a cohort of subjects; and d) determining the residual risk associated with the breast cancer; wherein a statistically significant difference or similarity in the expression of the group of genes compared to the reference expression level corresponds to a residual risk associated with breast cancer.
展开▼